Samuel George A. Iii Insider Trades

Insider Trading History

Track insider trading activity for Samuel George A. Iii. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel And Secretary
Holding Value $1.09M 900,000 shares
Last Trade
Mar 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.66M 900,000 shares
$1.84
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel And Secretary
Holding Value $40.6k 33,565 shares
Last Trade
Feb 11, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.9k 6,075 shares
$1.80
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel And Secretary
Holding Value $0 0 shares
Last Trade
Feb 11, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.9k 6,075 shares
$1.80
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel And Secretary
Holding Value $37.6k 31,063 shares
Last Trade
Feb 11, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.5k 2,502 shares
$1.80
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel And Secretary
Holding Value $33.3k 27,490 shares
Last Trade
Dec 19, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$109 65 shares
$1.68
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel And Secretary
Holding Value $33.3k 27,555 shares
Last Trade
Dec 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.92k 1,735 shares
$1.68
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel And Secretary
Holding Value $908k 750,000 shares
Last Trade
Mar 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$398k 750,000 shares
$0.53
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel
Holding Value $31.2k 25,820 shares
Last Trade
Feb 11, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.59k 2,440 shares
$0.65
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel
Holding Value $34.2k 28,260 shares
Last Trade
Feb 11, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.97k 6,076 shares
$0.65
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel
Holding Value $7.35k 6,075 shares
Last Trade
Feb 11, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.97k 6,076 shares
$0.65
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel
Holding Value $26.8k 22,184 shares
Last Trade
Nov 26, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9k 15,000 shares
$0.60
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $787k 650,000 shares
Last Trade
Mar 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$735k 650,000 shares
$1.13
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $14.7k 12,151 shares
Last Trade
Feb 11, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.56k 6,076 shares
$1.08
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $11.7k 9,674 shares
Last Trade
Feb 11, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.56k 6,076 shares
$1.08
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $8.69k 7,184 shares
Last Trade
Feb 11, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.69k 2,490 shares
$1.08
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $787k 650,000 shares
Last Trade
Mar 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$949k 650,000 shares
$1.46
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $4.35k 3,598 shares
Last Trade
Feb 11, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.35k 2,478 shares
$1.35
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $7.35k 6,076 shares
Last Trade
Feb 11, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.2k 6,076 shares
$1.35
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $22.1k 18,227 shares
Last Trade
Feb 11, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.2k 6,076 shares
$1.35
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $787k 650,000 shares
Last Trade
Mar 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$910k 650,000 shares
$1.40
$1.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up